Broad Institute, Takara Bio deal

Takara’s Clontech Laboratories Inc. subsidiary received non-exclusive rights to Broad’s IP related to CRISPR/ Cas9 gene editing system. CRISPR systems use small guide RNAs that pair with a target DNA...